Fundraising FoxAvlar BioVentures
Venture capitalMadingley · Series A–Growth
Find your way into Avlar BioVentures
Sign up to see every warm intro you have to Avlar BioVentures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avlar BioVentures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
Investments · 1 tracked
founders shown can be your intro path
Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersQuan CapitalSofinnova PartnersAstellas Venture Management LLCEMBL VenturesFuture Planet Capital+3 more
Frequently asked questions
- What stage does Avlar BioVentures invest at?
- Avlar BioVentures invests at the Series A, Series B, Series C, Growth stages.
- What sectors does Avlar BioVentures focus on?
- Avlar BioVentures focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Avlar BioVentures located?
- Avlar BioVentures is headquartered in Madingley, GB.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.
MDI Ventures is the corporate venture capital arm of Indonesian telecommunications company Telkom Indonesia, investing in high-growth technology startups across Southeast Asia and globally, with a focus on creating synergies between portfolio companies and Telkom Group and Indonesian state-owned enterprises.
Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.